Clinical Trial

Real-World Study of PADN for the Treatment of PAH

Recruiting
View on ClinicalTrials.gov →
Summary
Real-World Study of PADN for the Treatment of PAH
Trial Details
NCT Number NCT07039604
Lead Sponsor Pulnovo Medical (Wuxi) Co., Ltd.
Conditions Pulmonary Hypertension, Hypertension, Pulmonary Arterial
Enrollment 200 participants
Start Date 2025-03-19
Primary Completion 2028-12-30 (estimated)
Study Completion 2028-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-26